PEAK PlasmaBlade™ 4.0 Versus Traditional Electrosurgery in Mastectomy

Stopped early · Not applicable

Conditions studied: Mastectomy

In brief

The objective of this clinical study is to evaluate the incidence of partial skin necrosis following modified-radical mastectomy with or without same-day (two-stage) reconstruction with the PEAK PlasmaBlade 4.0; to monitor and record operative performance, post-operative pain, drain output, and skin scarring following surgery; and to compare these endpoints to the current standard of care (SOC).

Key facts

Study ID
NCT00943605
Run by
Medtronic Surgical Technologies
People needed
60
Starts
2009-06-01
Expected to finish
2012-03-01
Last updated by the study team
2013-01-08

Who can join

Age: 20 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.